Why pharma branded work didn’t make the Cannes cut
from The Refill, by MM+M Hosted by Marc Iskowitz, Collette Douaihy, Jack O'Brien, Lecia Bushak
Collette Douaihy, 2024 Cannes Lions Pharma jury president, CCO at Dentsu Health and 2024 MM+M Health Influencer, explains the dearth of award-caliber, regulated pharma work from this year’s festival in the south of France. Plus, Marc Iskowitz, Lecia Bushak and Jack O’Brien review recent Supreme Court decisions impacting healthcare. These include the court’s biggest abortion-related rulings since overturning Roe v. Wade two years ago to its rejection of the Purdue Pharma nationwide opioid settlement to its rollback of the 40-year-old Chevron defense. Is your team still treating AI like a side experiment while competitors use it to win? Cut through the buzzword fatigue. On November 12th, join hundreds of top marketers in New York City for AI Deciphered, presented by Campaign, MM+M, and PRWeek. Get real-world playbooks from leaders like Reddit’s Rob Gaige and Yahoo’s Matt Sanchez across dedicated tracks built for daily execution. Check us out at: mmm-online.com Follow us: YouTube: @MMM-online TikTok: @MMMnews Instagram: @MMMnewsonline Twitter/X: @MMMnews LinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.
Embed this episode
What this episode covers
Collette Douaihy, 2024 Cannes Lions Pharma jury president, explains the dearth of award-caliber, regulated pharma work from this year’s program. Plus, a review of recent SCOTUS decisions impacting healthcare.
No transcript yet.